Cardiovascular Health in Anxiety or Mood Problems Study (CHAMPS): study protocol for a randomized controlled trial

Table 2 Assessment schedule for participants through the study

			Timing of assessment for all participants
		Eligibility	Pre-random ization	4 weeks	8 weeks	12 weeks	18 weeks	6 months
Variable	Measure
Inclusion criteria
Depression	PHQ-9	✓		✓	✓	✓	✓	✓
Generalized anxiety	GAD-7	✓		✓	✓	✓	✓	✓
Psychiatric diagnosis	MINI	✓					✓	✓
Post-eligibility
Anxiety severity	OASIS		✓				✓	✓
General stress	DASS-21		✓				✓	✓
QOL	SF-12		✓				✓	✓
CVD outcome	MACE						✓	✓
Physical activity	Exercise		✓				✓	✓
GATS	Tobacco		✓				✓	✓
AUDIT-C	Alcohol		✓				✓	✓
MOS SAS	Adherence		✓
Psychiatric service, medication usage, satisfaction with care	Self-report, audit		✓				✓	✓

AUDIT-C, Alcohol Use Disorders Identification Test-Shortened Clinical Version; CVD, cardiovascular disease; DASS-21, Depression, Anxiety Stress Scales; GAD-7, Generalized Anxiety Disorder-7; GATS, Global Adult Tobacco Survey; MACE, major adverse cardiac event; MINI, MINI International Neuropsychiatric Interview; MOS SAS, Medical Outcomes Study Specific Adherence Scale; OASIS, Overall Anxiety Severity And Impairment Scale; PHQ-9, Patient Health Questionnaire-9; SF-12, Medical Outcomes Study Short Form-12; QOL, quality of life;

ISSN: 1745-6215